Point-of-Care Tissue Oxygenation Assessment with SnapshotNIR for Alloplastic and Autologous Breast Reconstruction.
Autor: | Moritz WR; From the Division of Plastic and Reconstructive Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Mo., Daines J; From the Division of Plastic and Reconstructive Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Mo., Christensen JM; From the Division of Plastic and Reconstructive Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Mo., Myckatyn T; From the Division of Plastic and Reconstructive Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Mo., Sacks JM; From the Division of Plastic and Reconstructive Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Mo., Westman AM; From the Division of Plastic and Reconstructive Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Mo. |
---|---|
Jazyk: | angličtina |
Zdroj: | Plastic and reconstructive surgery. Global open [Plast Reconstr Surg Glob Open] 2023 Jul 11; Vol. 11 (7), pp. e5113. Date of Electronic Publication: 2023 Jul 11 (Print Publication: 2023). |
DOI: | 10.1097/GOX.0000000000005113 |
Abstrakt: | In breast reconstruction, mastectomy and free flaps are susceptible to vascular compromise and tissue necrosis. The SnapshotNIR device (Kent Imaging, Calgary, AB, Canada) utilizes near-infrared spectroscopy to measure tissue oxygen saturation (StO Methods: Patients receiving immediate alloplastic reconstruction after mastectomy or autologous reconstruction were enrolled. Preoperative, intraoperative, and postoperative images were taken of the flaps. StO Results: Thirty-two breasts underwent alloplastic reconstruction; 38 breasts underwent autologous reconstruction. No enrollees developed skin necrosis. StO Conclusions: The SnapshotNIR device detected normal spatial and temporal differences in tissue oxygenation over the operative course of alloplastic and autologous breast reconstruction. A multi-institutional, prospective clinical trial is needed to determine the sensitivity and specificity of this device for detecting skin flap necrosis. Competing Interests: The SnapshotNIR devices used in this study were provided at no cost by Kent Imaging. Dr. Myckatyn receives investigator-initiated research funds from Sientra and RTI Surgical, and royalties from RTI Surgical. Dr. Sacks is a co-founder of LifeSprout Inc. (Baltimore, Md.) and holds an equity position. Dr. Sacks serves as a consultant for 3M. Dr. Westman receives research funds from 3M for preclinical studies. All the other authors have no financial interests to declare in relation to the content of this article. Disclosure statements are at the end of this article, following the correspondence information. (Copyright © 2023 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of The American Society of Plastic Surgeons.) |
Databáze: | MEDLINE |
Externí odkaz: |